Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine With or Without Trastuzumab in HER-2-Positive Metastatic Breast Cancer
NCT00103233Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Dec 2004
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by SWOG Cancer Research Network. Started Dec 2004; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00103233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103233.